Revenue: The sum of all revenue fields included for a company's operating activities.
Regeneron Pharmaceuticals, Inc. (REGN) had Revenue of $3.68B for the most recently reported fiscal quarter, ending 2025-06-30.
| Income Statement Financials | |
|
Revenue |
$3.68B |
$1.39B |
|
$530.20M |
|
$3.15B |
|
$2.60B |
|
$1.08B |
|
$439.20M |
|
$1.52B |
|
$1.52B |
|
$1.39B |
|
$1.39B |
|
$1.39B |
|
$1.39B |
|
$1.08B |
|
$1.21B |
|
105.10M |
|
108.60M |
|
$13.24 |
|
$12.81 |
|
| Balance Sheet Financials | |
$16.86B |
|
$4.84B |
|
$21.36B |
|
$38.22B |
|
$3.67B |
|
$2.71B |
|
$4.61B |
|
$8.28B |
|
$29.94B |
|
$28.59B |
|
$29.94B |
|
106.40M |
|
| Cash Flow Statement Financials | |
$2.19B |
|
$-446.50M |
|
$-2.22B |
|
$2.49B |
|
$2.02B |
|
$-473.40M |
|
$507.40M |
|
$-186.40M |
|
-- |
|
| Fundamental Metrics & Ratios | |
4.60 |
|
-- |
|
-- |
|
0.08 |
|
0.09 |
|
85.58% |
|
29.37% |
|
29.37% |
|
-- |
|
41.32% |
|
37.86% |
|
$1.74B |
|
-- |
|
-- |
|
-- |
|
0.10 |
|
0.17 |
|
0.66 |
|
137.37 |
|
4.65% |
|
4.87% |
|
3.64% |
|
4.26% |
|
$281.38 |
|
$16.03 |
|
$20.16 |
|